So I'm a sophomore at a target school. I am trying to decide if I should recruit for M&A or RX for my junior year summer internship. Any thoughts or advice? Would love to learn about how interesting the work is, exit opportunities (HF, PE), and how much I can learn through the experience. Thanks a lot!
| +247 | UBS Tech MD hires Son (from no-name college) as an Intern | 45 | 1h |
| +163 | WTF IS THIS COMPETITON | 59 | 1h |
| +161 | Mayday, Mayday: Key UBS Leaders (Former Barclays MDs) Abandoning Ship | 28 | 2d |
| +117 | Is banking in the south more sustainable? | 27 | 5h |
| +91 | The Intern Starter Pack | 15 | 6h |
| +75 | Current State of the League Tables | 28 | 4h |
| +48 | Perella Weinberg to Cut 10% of Workforce, Including Partners | 31 | 16h |
| +44 | [Official] 2026 IB Analyst Bonus Megathread (with 2025 Consolidated Pay and Perks/Benefits) | 8 | 18h |
| +38 | UBS Groups Ranked by Future Outlook | 20 | 20h |
| +32 | PWP Layoffs????? | 18 | 3d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Rx is a no-brainer if you want to do distressed HF/PE.
Rx is still a better option overall if you get into a place like PJT, HL, LAZ, EVR, Moelis, Gugg, Greenhill, PWP, etc. since you can pretty easily exit to vanilla PE as well, especially from a generalist program.
??? Except PJT/HL and maybe Lazard I’m taking M&A over restructuring for all the other shops you mentioned.
is EVR RX not on par with HL and LAZ?
what about Rothschild RX
Not a really great group anymore from what I've heard. Lost a ton of senior management in the last half decade to a few places, recently to TRS Advisors, and the brand name outside of Europe has been diminishing along with them.
Gugg and GHL are kind of an L compared to the others. Also I havent heard great things about PWP rx. The others are fire though
I would say Rx provides more optionality (with respect to PE & HF) in the sense that they get looks from HF a bit more than M&A, whereas PE looks are roughly comparable between M&A/Rx. That being said, groups like EVR M&A still get a ton of HF looks.
In general, Rx leans more HF exits and M&A leans more PE exits.
How does a place like Ducera or Miller Buckfire compare to the aforementioned Rx groups?
.
Below Rothschild? And what would they be better/worse for after 2yrs
how is working on M&A deals vs RX deals?
Perspiciatis error et tempore sit quis qui. Mollitia enim tenetur ipsam perspiciatis quo.
Quia itaque ducimus rerum aut aperiam nostrum quibusdam. Sit aut quod odio et.
Sequi dignissimos eos quaerat. Quis autem aut nihil illo eos labore autem sapiente.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...